BRIEF-Impax reports FDA approval of its AB rated generic concerta extended-release tablets CII (IPXL) | 07/17/17

July 17 (Reuters) – Impax Laboratories Inc:

* Impax announces FDA approval of its AB rated generic
concerta® (methylphenidate hydrochloride) extended-release
tablets CII

* Says don’t anticipate sales of generic concerta to
meaningfully impact earnings in 2017​

* Says ‍preparing for launch including working to secure api
quota and currently expect to launch by end of this year​
Source text for Eikon:
Further company coverage:


Get more stuff like this

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Show Comments

No Responses Yet

    Leave a Reply

    • Trade Algorithms with verified results. 6-8 procent. Click here to try a live free demoLive free demo